Literature DB >> 6606512

Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain.

J P Salier, P Glynn, J M Goust, M L Cuzner.   

Abstract

Concentrations of IgG allotypes G1m(1), G1m(3) and G3m(11) in neutral pH eluates from discrete plaques of multiple sclerosis (MS) brain and from white matter of control brain were determined to obtain information about distribution of B cell clones among MS lesions. Within each MS brain a predominant nominal IgG1 allotype was distributed rather homogeneously in all plaques while quantitatively minor allotypes showed some fluctuation. Latent IgG1 allotypes were detected (7-12% of the corresponding nominal allotype level) in some tissue eluates from both MS and control brains, which were homozygous for either G1m(1) or G1m(3). By contrast, the expression of a latent IgG3 allotype, namely G3m(11), was apparently MS restricted. Large amounts of latent allotypes were detected only in recent plaques with lymphoid cells whereas the distribution of total plaque associated IgGs did not correlate with the presence of lymphoid cells. Latent allotypes in recent MS lesions may mark a transient immunological activity which coincides with the infiltration of lymphoid cells and precedes the appearance in these plaques of oligoclonal IgGs, the distribution of which may parallel that of the predominant nominal allotypes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606512      PMCID: PMC1536170     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Immunoglobulin G distribution in multiple sclerosis brain. An immunofluorescence study.

Authors:  B F Tavolato
Journal:  J Neurol Sci       Date:  1975-01       Impact factor: 3.181

2.  Viral and bacterial antibody responses in multiple sclerosis.

Authors:  F Vartdal; B Vandvik; E Norrby
Journal:  Ann Neurol       Date:  1980-09       Impact factor: 10.422

3.  Quantitative studies of Gm allotypes--III. Some effects of IgG aggregation in radioimmunoassays using human IgM and rabbit IgG anti-Gm antibodies.

Authors:  J P Salier; H Sarvas; H M Reisner; A C Wang; H H Fudenberg
Journal:  Mol Immunol       Date:  1979-04       Impact factor: 4.407

4.  Analysis by transfer electrophoresis of reactivity of IgG with brain proteins in multiple sclerosis.

Authors:  J Newcombe; P Glynn; M L Cuzner
Journal:  J Neurochem       Date:  1982-10       Impact factor: 5.372

5.  Abnormal regulation of IgG production in multiple sclerosis.

Authors:  J M Goust; E L Hogan; P Arnaud
Journal:  Neurology       Date:  1982-03       Impact factor: 9.910

6.  Analysis of immunoglobulin G in multiple sclerosis brain: quantitative and isoelectric focusing studies.

Authors:  P Glynn; H M Gilbert; J Newcombe; M L Cuzner
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

7.  Oligoclonal IgG in multiple sclerosis and subacute sclerosing panencephalitis brains.

Authors:  D H Mattson; R P Roos; B G Arnason
Journal:  J Neuroimmunol       Date:  1982-06       Impact factor: 3.478

8.  Multiple sclerosis. Electrofocused "bands" of oligoclonal CSF IgG do not carry antibody activity against measles, varicella-zoster or rotaviruses.

Authors:  F Vartdal; B Vandvik
Journal:  J Neurol Sci       Date:  1982-04       Impact factor: 3.181

9.  Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system.

Authors:  M M Esiri
Journal:  Neuropathol Appl Neurobiol       Date:  1980 Jan-Feb       Impact factor: 8.090

10.  Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains.

Authors:  D H Mattson; R P Roos; B G Arnason
Journal:  Nature       Date:  1980-09-25       Impact factor: 49.962

View more
  5 in total

1.  Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

Authors:  C N Gaiser; M J Johnson; G de Lange; L Rassenti; L L Cavalli-Sforza; L Steinman
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

2.  Higher Levels of IgG3 Antibodies in Serum, But Not in CSF, Distinguish Multiple Sclerosis From Other Neurological Disorders.

Authors:  Peter G E Kennedy; Michael W Graner; Anthony Fringuello; Wenbo Zhou; Tiffany Pointon; Kinda Alquatli; Sara Bisel; Dianne Langford; Xiaoli Yu
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-06       Impact factor: 4.147

3.  Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.

Authors:  M J Walsh; W W Tourtellotte
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

4.  The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.

Authors:  Cheryl Beseler; Timothy Vollmer; Michael Graner; Xiaoli Yu
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

Review 5.  The Role of Antibodies in the Pathogenesis of Multiple Sclerosis.

Authors:  Xiaoli Yu; Michael Graner; Peter G E Kennedy; Yiting Liu
Journal:  Front Neurol       Date:  2020-10-20       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.